Fosun Pharma Subsidiary Wins Acceptance for Drug Registration Application

Reuters
2025.12.02 12:44
portai
I'm PortAI, I can summarize articles.

Shanghai Fosun Pharmaceutical announced that its subsidiary's drug registration application has been accepted. This information was published via the Issuer Information Service of the Hong Kong Stock Exchange.

Shanghai Fosun Pharmaceutical Announces Acceptance of Subsidiary’s Drug Registration Application Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Fosun Pharmaceutical (Group) Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251202-11940336), on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer